Adhesion structures in leukemia cells and their regulation by Src family kinases

References

• Guarino M. Src signaling in cancer invasion. J Cell Physiol 2010; 223:14-26; PMID:20049846
   PubMed Web of Science ®Google Scholar
• Huveneers S, Danen EH. Adhesion signaling - crosstalk between integrins, Src and Rho. J Cell Sci 2009; 122:1059-69; PMID:19339545; https://doi.org/10.1242/jcs.039446
   PubMed Web of Science ®Google Scholar
• Horton ER, Humphries JD, Stutchbury B, Jacquemet G, Ballestrem C, Barry ST, Humphries MJ. Modulation of FAK and Src adhesion signaling occurs independently of adhesion complex composition. J Cell Biol 2016; 212:349-64; PMID:26833789; https://doi.org/10.1083/jcb.201508080
   PubMed Web of Science ®Google Scholar
• del Rio A, Perez-Jimenez R, Liu R, Roca-Cusachs P, Fernandez JM, Sheetz MP. Stretching single talin rod molecules activates vinculin binding. Science 2009; 323:638-41; PMID:19179532; https://doi.org/10.1126/science.1162912
   PubMed Web of Science ®Google Scholar
• Yao M, Goult BT, Klapholz B, Hu X, Toseland CP, Guo Y, Cong P, Sheetz MP, Yan J. The mechanical response of talin. Nat Commun 2016; 7:11966; PMID:27384267; https://doi.org/10.1038/ncomms11966
   PubMed Web of Science ®Google Scholar
• Teckchandani A, Cooper JA. The ubiquitin-proteasome system regulates focal adhesions at the leading edge of migrating cells. Elife 2016; 5:pii: e17440; PMID:27656905; https://doi.org/10.7554/eLife.17440
   PubMed Web of Science ®Google Scholar
• Ingley E. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Signal 2012; 10:21; PMID:22805580; https://doi.org/10.1186/1478-811X-10-21
   PubMed Web of Science ®Google Scholar
• Abram CL, Lowell CA. The diverse functions of Src family kinases in macrophages. Front Biosci 2008; 13:4426-50 [pii]; PMID:18508521; https://doi.org/10.2741/3015
   PubMed Web of Science ®Google Scholar
• He Y, Kapoor A, Cook S, Liu S, Xiang Y, Rao CV, Kenis PJ, Wang F. The non-receptor tyrosine kinase Lyn controls neutrophil adhesion by recruiting the CrkL-C3G complex and activating Rap1 at the leading edge. J Cell Sci 2011; 124:2153-64; PMID:21628423; https://doi.org/10.1242/jcs.078535
   PubMed Web of Science ®Google Scholar
• Orschell CM, Borneo J, Munugalavadla V, Ma P, Sims E, Ramdas B, Yoder MC, Kapur R. Deficiency of Src family kinases compromises the repopulating ability of hematopoietic stem cells. Exp Hematol 2008; 36:655-66; PMID:18346837; https://doi.org/10.1016/j.exphem.2008.01.002
   PubMed Web of Science ®Google Scholar
• Zhi H, Dai J, Liu J, Zhu J, Newman DK, Gao C, Newman PJ. Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin alphaIIbbeta3 and Lyn Kinase. PLoS One 2015; 10:e0135738; PMID:26291522; https://doi.org/10.1371/journal.pone.0135738
   PubMed Web of Science ®Google Scholar
• Penzes K, Baumann C, Szabadkai I, Orfi L, Keri G, Ullrich A, Torka R. Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells. Cancer Biol Ther 2014; 15:1571-82; PMID:25482942; https://doi.org/10.4161/15384047.2014.956634
   PubMed Web of Science ®Google Scholar
• Roseweir AK, Qayyum T, Lim Z, Hammond R, MacDonald AI, Fraser S, Oades GM, Aitchison M, Jones RJ, Edwards J. Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients. BMC Cancer 2016; 16:229, 016-2254-9; PMID:26984511; https://doi.org/10.1186/s12885-016-2254-9
   PubMed Web of Science ®Google Scholar
• Pham H, Birtolo C, Chheda C, Yang W, Rodriguez MD, Liu ST, Gugliotta G, Lewis MS, Cirulli V, Pandol SJ, et al. Essential role of lyn in Fibrosis. Front Physiol 2016; 7:387; PMID:27630579; https://doi.org/10.3389/fphys.2016.00387
   PubMed Web of Science ®Google Scholar
• Han J, Zhang G, Welch EJ, Liang Y, Fu J, Vogel SM, Lowell CA, Du X, Cheresh DA, Malik AB, et al. A critical role for Lyn kinase in strengthening endothelial integrity and barrier function. Blood 2013; 122:4140-9; PMID:24108461; https://doi.org/10.1182/blood-2013-03-491423
   PubMed Web of Science ®Google Scholar
• Hong H, Kitaura J, Xiao W, Horejsi V, Ra C, Lowell CA, Kawakami Y, Kawakami T. The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood 2007; 110:2511-9; PMID:17513616; https://doi.org/10.1182/blood-2007-01-066092
   PubMed Web of Science ®Google Scholar
• Obr A, Roselova P, Grebenova D, Kuzelova K. Real-time analysis of imatinib- and dasatinib-induced effects on chronic myelogenous leukemia cell interaction with fibronectin. PLoS One 2014; 9:e107367; PMID:25198091; https://doi.org/10.1371/journal.pone.0107367
   PubMed Web of Science ®Google Scholar
• Michaelis S, Wegener J, Robelek R. Label-free monitoring of cell-based assays: combining impedance analysis with SPR for multiparametric cell profiling. Biosens Bioelectron 2013; 49:63-70; PMID:23711901; https://doi.org/10.1016/j.bios.2013.04.042
   PubMed Web of Science ®Google Scholar
• Scielzo C, Bertilaccio MT, Simonetti G, Dagklis A, ten Hacken E, Fazi C, Muzio M, Caiolfa V, Kitamura D, Restuccia U, et al. HS1 has a central role in the trafficking and homing of leukemic B cells. Blood 2010; 116:3537-46; PMID:20530793; https://doi.org/10.1182/blood-2009-12-258814
   PubMed Web of Science ®Google Scholar
• Wegener J, Keese CR, Giaever I. Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. Exp Cell Res 2000; 259:158-66; PMID:10942588; https://doi.org/10.1006/excr.2000.4919
   PubMed Web of Science ®Google Scholar
• Obr A, Roselova P, Grebenova D, Kuzelova K. Real-time monitoring of hematopoietic cell interaction with fibronectin fragment: The effect of histone deacetylase inhibitors. Cell Adh Migr 2013; 7:275-82; PMID:23567296; https://doi.org/10.4161/cam.24531
   PubMed Web of Science ®Google Scholar
• Prosper F, Verfaillie CM. Regulation of hematopoiesis through adhesion receptors. J Leukoc Biol 2001; 69:307-16; PMID:11261776
   PubMed Web of Science ®Google Scholar
• Martin-Henao GA, Quiroga R, Sureda A, Gonzalez JR, Moreno V, Garcia J. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression. Haematologica 2000; 85:139-46
   PubMed Web of Science ®Google Scholar
• Jin L, Tabe Y, Konoplev S, Xu Y, Leysath CE, Lu H, Kimura S, Ohsaka A, Rios MB, Calvert L, et al. CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Molecular Cancer Therapeutics 2008; 7:48-58; PMID:18202009; https://doi.org/10.1158/1535-7163.MCT-07-0042
   PubMed Web of Science ®Google Scholar
• Chen YY, Malik M, Tomkowicz BE, Collman RG, Ptasznik A. BCR-ABL1 alters SDF-1alpha-mediated adhesive responses through the beta2 integrin LFA-1 in leukemia cells. Blood 2008; 111:5182-6; PMID:18339898; https://doi.org/10.1182/blood-2007-10-117705
   PubMed Web of Science ®Google Scholar
• Daubon T, Rochelle T, Bourmeyster N, Genot E. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells. Eur J Cell Biol 2012; 91:978-87; PMID:22717125; https://doi.org/10.1016/j.ejcb.2012.04.006
   PubMed Web of Science ®Google Scholar
• Konig H, Holtz M, Modi H, Manley P, Holyoake TL, Forman SJ, Bhatia R. Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia 2008; 22:748-55; PMID:18273048; https://doi.org/10.1038/sj.leu.2405086
   PubMed Web of Science ®Google Scholar
• Weisberg E, Wright RD, McMillin DW, Mitsiades C, Ray A, Barrett R, Adamia S, Stone R, Galinsky I, Kung AL, et al. Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells. Mol Cancer Ther 2008; 7:1121-9; PMID:18445657; https://doi.org/10.1158/1535-7163.MCT-07-2331
   PubMed Web of Science ®Google Scholar
• Becker PS. Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment. ScientificWorldJournal 2012; 2012:856467; PMID:22346731; https://doi.org/10.1100/2012/856467
   PubMed Web of Science ®Google Scholar
• Brault L, Rovo A, Decker S, Dierks C, Tzankov A, Schwaller J. CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia. Leukemia 2014; 28:566-76; PMID:23817178; https://doi.org/10.1038/leu.2013.201
   PubMed Web of Science ®Google Scholar
• Hanke M, Hoffmann I, Christophis C, Schubert M, Hoang VT, Zepeda-Moreno A, Baran N, Eckstein V, Wuchter P, Rosenhahn A, et al. Differences between healthy hematopoietic progenitors and leukemia cells with respect to CD44 mediated rolling versus adherence behavior on hyaluronic acid coated surfaces. Biomaterials 2014; 35:1411-9; https://doi.org/10.1016/j.biomaterials.2013.11.011
   PubMed Web of Science ®Google Scholar
• Gattazzo C, Martini V, Frezzato F, Trimarco V, Tibaldi E, Castelli M, Facco M, Zonta F, Brunati AM, Zambello R, et al. Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. Haematologica 2014; 99(6):1069-77; https://doi.org/10.3324/haematol.2013.090183
   PubMed Web of Science ®Google Scholar
• Li S. Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. Leuk Lymphoma 2008; 49:19-26; PMID:18203007; https://doi.org/10.1080/10428190701713689
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu Y, Pelletier S, Buchdunger E, Warmuth M, Fabbro D, Hallek M, Van Etten RA, Li S. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet 2004; 36:453-61; PMID:15098032; https://doi.org/10.1038/ng1343
   PubMed Web of Science ®Google Scholar
• Dos Santos C, McDonald T, Ho YW, Liu H, Lin A, Forman SJ, Kuo YH, Bhatia R. The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents. Blood 2013; 122:1900-13; PMID:23896410; https://doi.org/10.1182/blood-2012-11-466425
   PubMed Web of Science ®Google Scholar
• Gertz MA. New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression. Leuk Lymphoma 2008; 49:2240-5; PMID:19052970; https://doi.org/10.1080/10428190802475311
   PubMed Web of Science ®Google Scholar
• Veldurthy A, Patz M, Hagist S, Pallasch CP, Wendtner CM, Hallek M, Krause G. The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes. Blood 2008; 112:1443-52; PMID:18550857; https://doi.org/10.1182/blood-2007-11-123984
   PubMed Web of Science ®Google Scholar
• ten Hacken E, Scielzo C, Bertilaccio MT, Scarfò L, Apollonio B, Barbaglio F, Stamatopoulos K, Ponzoni M, Ghia P, Caligaris-Cappio F. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia. Blood 2013; 121:2264-73; PMID:23325840; https://doi.org/10.1182/blood-2012-09-457119
   PubMed Web of Science ®Google Scholar
• Horton ER, Byron A, Askari JA, Ng DH, Millon-Fremillon A, Robertson J, Koper EJ, Paul NR, Warwood S, Knight D, et al. Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly. Nat Cell Biol 2015; 17:1577-87; PMID:26479319; https://doi.org/10.1038/ncb3257
   PubMed Web of Science ®Google Scholar
• Kaplan KB, Bibbins KB, Swedlow JR, Arnaud M, Morgan DO, Varmus HE. Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J 1994; 13:4745-56; PMID:7525268
   PubMed Web of Science ®Google Scholar
• Fincham VJ, Frame MC. The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J 1998; 17:81-92; PMID:9427743; https://doi.org/10.1093/emboj/17.1.81
   PubMed Web of Science ®Google Scholar
• Jarvinen M, Ylanne J, Vartio T, Virtanen I. Tumor promoter and fibronectin induce actin stress fibers and focal adhesion sites in spreading human erythroleukemia (HEL) cells. Eur J Cell Biol 1987; 44:238-46; PMID:3319626
   PubMed Web of Science ®Google Scholar
• Ylanne J, Cheresh DA, Virtanen I. Localization of beta 1, beta 3, alpha 5, alpha v, and alpha IIb subunits of the integrin family in spreading human erythroleukemia cells. Blood 1990; 76:570-7; PMID:1696147
   PubMed Web of Science ®Google Scholar
• O'Laughlin-Bunner B, Radosevic N, Taylor ML, Shivakrupa DeBerry C, Metcalfe DD, Zhou M, Lowell C, Linnekin D. Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells. Blood 2001; 98:343-50; PMID:11435302; https://doi.org/10.1182/blood.V98.2.343
   PubMed Web of Science ®Google Scholar
• Tsuji-Takayama K, Kamiya T, Nakamura S, Matsuo Y, Adachi T, Tsubota T, Imanishi J, Minowada J. Establishment of multiple leukemia cell lines with diverse myeloid and/or megakaryoblastoid characteristics from a single Ph1 positive chronic myelogenous leukemia blood sample. Hum Cell 1994; 7:167-71; PMID:7873501
   PubMedGoogle Scholar
• Kuzelova K, Pluskalova M, Brodska B, Otevrelova P, Elknerova K, Grebenova D, Hrkal Z. Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin. J Cell Biochem 2010; 109:184-95; PMID:19911379; https://doi.org/10.1002/jcb.22397
   PubMed Web of Science ®Google Scholar